ClinicalTrials.Veeva

Menu

Platelet Rich Plasma Study in Lower Extremity Bypass Surgery (PRP)

L

Lawson Health Research Institute

Status

Completed

Conditions

Atherosclerosis

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT00517452
R-07-098

Details and patient eligibility

About

The use of platelet rich plasma will decrease wound infection postop.

Enrollment

81 patients

Sex

All

Ages

35 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Vascular surgical patients scheduled for elective lower extremity bypass surgery,aortoiliac revascularizations and endovascular AAA repair requiring a groin incision Exclusion Criteria:Patients requiring emergent procedures, unable to give informed consent

Trial design

81 participants in 2 patient groups

Platelet Rich Plasma
Description:
Group received platelet rich plasma and observed over a period of 30 days or until wound closure
Standard Wound Care
Description:
Group was treated as per standard care

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems